Market Place
Sourcing Support
All News #Library
Biotech
Revolution Issues Legal Threat to Erasca as Rivalry Heats
29 Apr 2026 //
BIOSPACE
Erasca Updates 2025 Q4 Business Updates And Financial Results
12 Mar 2026 //
GLOBENEWSWIRE
Erasca Secures Global Rights to ERAS-0015 Pan-RAS Molecular Glue
10 Mar 2026 //
GLOBENEWSWIRE
Tango Therapeutics Reports 2025 Financial & Business Updates
05 Mar 2026 //
GLOBENEWSWIRE
Erasca Issues U.S. Patent For Pan-Kras Inhibitor ERAS-4001
24 Feb 2026 //
GLOBENEWSWIRE
Erasca To Present At Upcoming Conferences In February
05 Feb 2026 //
GLOBENEWSWIRE
Erasca Closes Upsized Offering; Underwriters Exercise Full Option
23 Jan 2026 //
GLOBENEWSWIRE
Functional Force Platforms to Disrupt Tumors by 2026
16 Jan 2026 //
PR NEWSWIRE
Erasca Announces Promising ERAS-0015 Data & 2026-2027 Milestone
12 Jan 2026 //
GLOBENEWSWIRE
Erasca To Present At Evercore Healthcare Conference
25 Nov 2025 //
GLOBENEWSWIRE
Erasca Secures U.S. Patent For Pan-Ras Molecular Glue ERAS-0015
06 Nov 2025 //
GLOBENEWSWIRE
Erasca to Present at Morgan Stanley Global Healthcare Conference
02 Sep 2025 //
GLOBENEWSWIRE
Erasca`s Q2 2025 Business Updates and Financial Results
12 Aug 2025 //
GLOBENEWSWIRE
Erasca looks to partner off late-stage melanoma asset
14 May 2025 //
FIERCE BIOTECH
Erasca Shows Preclinical Data on RAS at 2025 AACR Meeting
29 Apr 2025 //
GLOBENEWSWIRE
Erasca to Present at the Guggenheim Cap Biotech Conference
31 Jan 2025 //
GLOBENEWSWIRE
Erasca Reports Second Quarter 2024 Business Updates and Financial Results
12 Aug 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.